

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.39886554 |
| 2 | neuronal action potential propagation (GO:0019227) | 5.19318701 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.03645524 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.97579611 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.93929696 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.93204035 |
| 7 | vocalization behavior (GO:0071625) | 4.89308307 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.85057404 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.84059733 |
| 10 | glutamate secretion (GO:0014047) | 4.72254834 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.69356986 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.58689475 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.57673866 |
| 14 | sodium ion export (GO:0071436) | 4.57355807 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.41610188 |
| 16 | protein localization to synapse (GO:0035418) | 4.35682299 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.23657378 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.12547814 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.08354020 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.07444575 |
| 21 | presynaptic membrane assembly (GO:0097105) | 4.06551949 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.04897542 |
| 23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.00646198 |
| 24 | * neuron-neuron synaptic transmission (GO:0007270) | 3.99353175 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.93575621 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.93266194 |
| 27 | presynaptic membrane organization (GO:0097090) | 3.92802140 |
| 28 | exploration behavior (GO:0035640) | 3.90754169 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.90386771 |
| 30 | L-amino acid import (GO:0043092) | 3.85488092 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.83985070 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.82933363 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.82913546 |
| 34 | detection of calcium ion (GO:0005513) | 3.80250932 |
| 35 | transmission of nerve impulse (GO:0019226) | 3.77039646 |
| 36 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.75639036 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66925382 |
| 38 | potassium ion homeostasis (GO:0055075) | 3.63096663 |
| 39 | neuron recognition (GO:0008038) | 3.63028016 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.61262150 |
| 41 | neurotransmitter transport (GO:0006836) | 3.56105499 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.53545236 |
| 43 | long-term memory (GO:0007616) | 3.53491774 |
| 44 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.53341225 |
| 45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.53087448 |
| 46 | cellular potassium ion homeostasis (GO:0030007) | 3.49691969 |
| 47 | postsynaptic membrane organization (GO:0001941) | 3.48917333 |
| 48 | long-term synaptic potentiation (GO:0060291) | 3.45787189 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.44692431 |
| 50 | central nervous system myelination (GO:0022010) | 3.43951401 |
| 51 | axon ensheathment in central nervous system (GO:0032291) | 3.43951401 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.42182246 |
| 53 | potassium ion import (GO:0010107) | 3.36105277 |
| 54 | glycine transport (GO:0015816) | 3.35945458 |
| 55 | neuromuscular process controlling posture (GO:0050884) | 3.35116167 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.34320128 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.34031767 |
| 58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32986802 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.30418573 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.29606337 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.26648267 |
| 62 | cellular sodium ion homeostasis (GO:0006883) | 3.26600913 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.25347347 |
| 64 | axonal fasciculation (GO:0007413) | 3.24759498 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.23296295 |
| 66 | cell communication by electrical coupling (GO:0010644) | 3.22629785 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 3.22509591 |
| 68 | positive regulation of dendritic spine development (GO:0060999) | 3.22449807 |
| 69 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.19475567 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.18941095 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.18617281 |
| 72 | negative regulation of neurotransmitter transport (GO:0051589) | 3.17280688 |
| 73 | proline transport (GO:0015824) | 3.16021068 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.15426070 |
| 75 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.15133033 |
| 76 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13081016 |
| 77 | acidic amino acid transport (GO:0015800) | 3.12434079 |
| 78 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.10686119 |
| 79 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10578383 |
| 80 | * adult walking behavior (GO:0007628) | 3.10170019 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.09933898 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.09162492 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.08422921 |
| 84 | membrane hyperpolarization (GO:0060081) | 3.08312936 |
| 85 | amino acid import (GO:0043090) | 3.07732481 |
| 86 | neuronal ion channel clustering (GO:0045161) | 3.07111587 |
| 87 | membrane depolarization (GO:0051899) | 3.05076838 |
| 88 | C4-dicarboxylate transport (GO:0015740) | 3.04233892 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.02494687 |
| 90 | synaptic vesicle transport (GO:0048489) | 3.01683442 |
| 91 | establishment of synaptic vesicle localization (GO:0097480) | 3.01683442 |
| 92 | auditory behavior (GO:0031223) | 3.00369922 |
| 93 | synapse assembly (GO:0007416) | 3.00041591 |
| 94 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.98245990 |
| 95 | response to auditory stimulus (GO:0010996) | 2.98245481 |
| 96 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93432379 |
| 97 | cerebellar Purkinje cell layer development (GO:0021680) | 2.92882460 |
| 98 | * synaptic transmission (GO:0007268) | 2.91565873 |
| 99 | learning (GO:0007612) | 2.91525536 |
| 100 | membrane depolarization during action potential (GO:0086010) | 2.90890816 |
| 101 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89264222 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 2.88381372 |
| 103 | response to histamine (GO:0034776) | 2.87666168 |
| 104 | neurotransmitter uptake (GO:0001504) | 2.86707866 |
| 105 | positive regulation of synapse assembly (GO:0051965) | 2.86553993 |
| 106 | dendrite morphogenesis (GO:0048813) | 2.86307365 |
| 107 | mechanosensory behavior (GO:0007638) | 2.86165085 |
| 108 | behavioral response to cocaine (GO:0048148) | 2.84666699 |
| 109 | regulation of synaptic transmission (GO:0050804) | 2.84481019 |
| 110 | neuromuscular synaptic transmission (GO:0007274) | 2.84148904 |
| 111 | negative regulation of dendrite development (GO:2000171) | 2.83578756 |
| 112 | chemosensory behavior (GO:0007635) | 2.82811656 |
| 113 | serotonin metabolic process (GO:0042428) | 2.82260722 |
| 114 | positive regulation of synaptic transmission (GO:0050806) | 2.82256654 |
| 115 | activation of protein kinase A activity (GO:0034199) | 2.80237613 |
| 116 | regulation of glutamate secretion (GO:0014048) | 2.79636517 |
| 117 | positive regulation of synapse maturation (GO:0090129) | 2.79400453 |
| 118 | behavioral defense response (GO:0002209) | 2.78081064 |
| 119 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77480074 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.77103468 |
| 121 | regulation of dendritic spine development (GO:0060998) | 2.76556126 |
| 122 | vesicle transport along microtubule (GO:0047496) | 2.76327435 |
| 123 | mating behavior (GO:0007617) | 2.75968137 |
| 124 | regulation of respiratory system process (GO:0044065) | 2.74807121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.23244817 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.99824341 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07084803 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98722251 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94527933 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56924576 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56924576 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55600596 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47855839 |
| 10 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45348998 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42976120 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42573534 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40136604 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38702708 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37158924 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33473844 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23683701 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17871770 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13659210 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11889565 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06562777 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.04775825 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96953596 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96371832 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95341314 |
| 26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91378966 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91024369 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84988404 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81929369 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77551561 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75558509 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69093256 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69014292 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67613051 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62827680 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62413462 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60699473 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59572021 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51769920 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51377161 |
| 41 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48908015 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47367270 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47173944 |
| 44 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44843985 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44427989 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42722139 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39709576 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37941494 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34550651 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34275336 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33568073 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.32557958 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29194301 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28199157 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27277681 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26297124 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25577685 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24156017 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23502112 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23131477 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21406581 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21205069 |
| 63 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.19546591 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19530338 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17939059 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16838330 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16606466 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16488463 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16345177 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15687457 |
| 71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15276641 |
| 72 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.15151327 |
| 73 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13692088 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11985842 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11714009 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11123099 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09169020 |
| 78 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09001323 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08684761 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08602174 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.07832103 |
| 82 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07390083 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06920278 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05952515 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03946505 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03796685 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03314998 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01840492 |
| 89 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.01785604 |
| 90 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01411212 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00944600 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00617259 |
| 93 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00304740 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99991855 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99158540 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98912728 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98892112 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98747853 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98449232 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97903129 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97507740 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96916116 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96841186 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96841186 |
| 105 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96350542 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95016881 |
| 107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94911759 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94789058 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94573640 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 0.94419870 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93212339 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92561614 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87527068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.46206525 |
| 2 | MP0003880_abnormal_central_pattern | 5.17765644 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.91699391 |
| 4 | MP0004270_analgesia | 3.51633452 |
| 5 | MP0009745_abnormal_behavioral_response | 3.42459270 |
| 6 | * MP0009046_muscle_twitch | 3.27810675 |
| 7 | MP0002064_seizures | 3.26421547 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.06646182 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.99277170 |
| 10 | MP0002272_abnormal_nervous_system | 2.88786769 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.75981535 |
| 12 | * MP0001486_abnormal_startle_reflex | 2.72220329 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.63976503 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.61021368 |
| 15 | MP0002736_abnormal_nociception_after | 2.43915014 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.28631405 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.27236060 |
| 18 | MP0002822_catalepsy | 2.23824535 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.23216644 |
| 20 | * MP0002067_abnormal_sensory_capabilities | 2.11561709 |
| 21 | MP0001970_abnormal_pain_threshold | 1.95812335 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.93956352 |
| 23 | MP0008569_lethality_at_weaning | 1.92736847 |
| 24 | MP0001529_abnormal_vocalization | 1.90149821 |
| 25 | MP0000778_abnormal_nervous_system | 1.81140587 |
| 26 | MP0003329_amyloid_beta_deposits | 1.80214017 |
| 27 | MP0004924_abnormal_behavior | 1.79698053 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.79698053 |
| 29 | MP0005171_absent_coat_pigmentation | 1.78265710 |
| 30 | MP0002184_abnormal_innervation | 1.76389922 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.73125500 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.67404035 |
| 33 | * MP0002557_abnormal_social/conspecific_i | 1.65588053 |
| 34 | MP0004885_abnormal_endolymph | 1.64978641 |
| 35 | MP0001905_abnormal_dopamine_level | 1.62142962 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.60972328 |
| 37 | MP0000920_abnormal_myelination | 1.58349848 |
| 38 | * MP0004142_abnormal_muscle_tone | 1.57394053 |
| 39 | MP0001188_hyperpigmentation | 1.56799364 |
| 40 | * MP0000955_abnormal_spinal_cord | 1.51697225 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.48739095 |
| 42 | MP0004742_abnormal_vestibular_system | 1.47404990 |
| 43 | MP0001984_abnormal_olfaction | 1.46107342 |
| 44 | * MP0002066_abnormal_motor_capabilities/c | 1.44792386 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.44109657 |
| 46 | * MP0002882_abnormal_neuron_morphology | 1.42610057 |
| 47 | MP0003879_abnormal_hair_cell | 1.38034220 |
| 48 | MP0003787_abnormal_imprinting | 1.37639009 |
| 49 | MP0003633_abnormal_nervous_system | 1.35350696 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.27302895 |
| 51 | MP0003690_abnormal_glial_cell | 1.25595396 |
| 52 | MP0004858_abnormal_nervous_system | 1.25416198 |
| 53 | MP0003631_nervous_system_phenotype | 1.22156119 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.20627939 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.20495160 |
| 56 | MP0002229_neurodegeneration | 1.18672919 |
| 57 | MP0005409_darkened_coat_color | 1.12838336 |
| 58 | MP0003136_yellow_coat_color | 1.11030457 |
| 59 | MP0001963_abnormal_hearing_physiology | 1.08277445 |
| 60 | MP0003122_maternal_imprinting | 1.08274035 |
| 61 | MP0003634_abnormal_glial_cell | 1.07030791 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.06264259 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.05085931 |
| 64 | MP0003632_abnormal_nervous_system | 1.02169744 |
| 65 | * MP0002152_abnormal_brain_morphology | 1.00383608 |
| 66 | MP0004147_increased_porphyrin_level | 0.97461235 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.92628800 |
| 68 | MP0001177_atelectasis | 0.91236118 |
| 69 | MP0008872_abnormal_physiological_respon | 0.90818001 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.90261509 |
| 71 | MP0008877_abnormal_DNA_methylation | 0.89500992 |
| 72 | MP0003123_paternal_imprinting | 0.89420889 |
| 73 | * MP0002752_abnormal_somatic_nervous | 0.88374987 |
| 74 | MP0002069_abnormal_eating/drinking_beha | 0.84160165 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.84107207 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 0.82557913 |
| 77 | MP0008874_decreased_physiological_sensi | 0.80669414 |
| 78 | MP0004043_abnormal_pH_regulation | 0.79099468 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.77682921 |
| 80 | MP0000751_myopathy | 0.77097468 |
| 81 | MP0002090_abnormal_vision | 0.76021993 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.74724906 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.74210056 |
| 84 | MP0005535_abnormal_body_temperature | 0.73490515 |
| 85 | MP0000604_amyloidosis | 0.73378568 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.72518315 |
| 87 | MP0003121_genomic_imprinting | 0.71270409 |
| 88 | MP0004085_abnormal_heartbeat | 0.70161789 |
| 89 | MP0000026_abnormal_inner_ear | 0.70136328 |
| 90 | MP0001664_abnormal_digestion | 0.68714806 |
| 91 | MP0004484_altered_response_of | 0.68565924 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.66917098 |
| 93 | MP0002102_abnormal_ear_morphology | 0.62570369 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.62541889 |
| 95 | MP0003283_abnormal_digestive_organ | 0.62357765 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.62186064 |
| 97 | MP0005394_taste/olfaction_phenotype | 0.60735642 |
| 98 | MP0005499_abnormal_olfactory_system | 0.60735642 |
| 99 | MP0005253_abnormal_eye_physiology | 0.60494339 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.58627552 |
| 101 | MP0001943_abnormal_respiration | 0.57500807 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.56277755 |
| 103 | * MP0010769_abnormal_survival | 0.55500826 |
| 104 | * MP0002082_postnatal_lethality | 0.55482305 |
| 105 | * MP0010770_preweaning_lethality | 0.55482305 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.55258807 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.53094256 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.52982786 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.52566227 |
| 110 | * MP0010768_mortality/aging | 0.52547376 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.51685387 |
| 112 | * MP0003956_abnormal_body_size | 0.50569486 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.50475819 |
| 114 | MP0003861_abnormal_nervous_system | 0.50320301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.18090401 |
| 2 | Myokymia (HP:0002411) | 5.88875843 |
| 3 | Focal seizures (HP:0007359) | 5.54816043 |
| 4 | Atonic seizures (HP:0010819) | 5.14652296 |
| 5 | Febrile seizures (HP:0002373) | 4.95533330 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.87018426 |
| 7 | Visual hallucinations (HP:0002367) | 4.61754805 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.20314032 |
| 9 | Absence seizures (HP:0002121) | 4.13661474 |
| 10 | Dialeptic seizures (HP:0011146) | 3.97363684 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.94842555 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.67805575 |
| 13 | Action tremor (HP:0002345) | 3.64618063 |
| 14 | Broad-based gait (HP:0002136) | 3.58872880 |
| 15 | Hyperventilation (HP:0002883) | 3.51867404 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.49062985 |
| 17 | Dysmetria (HP:0001310) | 3.28238459 |
| 18 | Ankle clonus (HP:0011448) | 3.26132077 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.24106802 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.21243943 |
| 21 | Scanning speech (HP:0002168) | 3.01818053 |
| 22 | Truncal ataxia (HP:0002078) | 2.94643289 |
| 23 | Abnormality of the corticospinal tract (HP:0002492) | 2.93475068 |
| 24 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.88699437 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.88699437 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85081165 |
| 27 | Anxiety (HP:0000739) | 2.82287804 |
| 28 | Poor eye contact (HP:0000817) | 2.81528982 |
| 29 | Blue irides (HP:0000635) | 2.81437101 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 2.80108325 |
| 31 | Spastic gait (HP:0002064) | 2.75643406 |
| 32 | Depression (HP:0000716) | 2.75520060 |
| 33 | Progressive inability to walk (HP:0002505) | 2.73663502 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.73598786 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.73595146 |
| 36 | Hemiparesis (HP:0001269) | 2.70657737 |
| 37 | Intention tremor (HP:0002080) | 2.67086503 |
| 38 | Pheochromocytoma (HP:0002666) | 2.64430517 |
| 39 | Absent speech (HP:0001344) | 2.59031428 |
| 40 | Drooling (HP:0002307) | 2.58677897 |
| 41 | Excessive salivation (HP:0003781) | 2.58677897 |
| 42 | Postural instability (HP:0002172) | 2.58306916 |
| 43 | Diplopia (HP:0000651) | 2.57386134 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.57386134 |
| 45 | Amblyopia (HP:0000646) | 2.56306354 |
| 46 | Delusions (HP:0000746) | 2.56160458 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.53154508 |
| 48 | Termporal pattern (HP:0011008) | 2.50993060 |
| 49 | Insidious onset (HP:0003587) | 2.50993060 |
| 50 | Impaired social interactions (HP:0000735) | 2.46219563 |
| 51 | Abnormal social behavior (HP:0012433) | 2.46219563 |
| 52 | Urinary urgency (HP:0000012) | 2.43192825 |
| 53 | Peripheral hypomyelination (HP:0007182) | 2.41843960 |
| 54 | Fetal akinesia sequence (HP:0001989) | 2.41623559 |
| 55 | Cerebral hypomyelination (HP:0006808) | 2.41280899 |
| 56 | Limb dystonia (HP:0002451) | 2.37935691 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.35534635 |
| 58 | Tetraplegia (HP:0002445) | 2.28638032 |
| 59 | Neuroendocrine neoplasm (HP:0100634) | 2.28430650 |
| 60 | Mutism (HP:0002300) | 2.28057805 |
| 61 | Inability to walk (HP:0002540) | 2.27188712 |
| 62 | Generalized myoclonic seizures (HP:0002123) | 2.27145088 |
| 63 | Craniofacial dystonia (HP:0012179) | 2.26449757 |
| 64 | Lower limb muscle weakness (HP:0007340) | 2.22307421 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.20930310 |
| 66 | Sleep apnea (HP:0010535) | 2.17775693 |
| 67 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14906986 |
| 68 | Impaired smooth pursuit (HP:0007772) | 2.14180988 |
| 69 | Retinal dysplasia (HP:0007973) | 2.13477214 |
| 70 | Status epilepticus (HP:0002133) | 2.12627565 |
| 71 | Bradykinesia (HP:0002067) | 2.12282917 |
| 72 | Gait imbalance (HP:0002141) | 2.10575943 |
| 73 | Clonus (HP:0002169) | 2.10171873 |
| 74 | Megalencephaly (HP:0001355) | 2.09549470 |
| 75 | Akinesia (HP:0002304) | 2.09253146 |
| 76 | Hemiplegia (HP:0002301) | 2.08674006 |
| 77 | Genetic anticipation (HP:0003743) | 2.06190629 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.05585143 |
| 79 | Diminished movement (HP:0002374) | 2.04561500 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 2.03558295 |
| 81 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.03558295 |
| 82 | Aplasia of the phalanges of the hand (HP:0009802) | 2.03558295 |
| 83 | Torticollis (HP:0000473) | 2.02436122 |
| 84 | Polyphagia (HP:0002591) | 2.01576934 |
| 85 | Sensory axonal neuropathy (HP:0003390) | 2.01340464 |
| 86 | Spastic tetraplegia (HP:0002510) | 2.01209647 |
| 87 | Apathy (HP:0000741) | 1.99345054 |
| 88 | Impaired vibratory sensation (HP:0002495) | 1.96344981 |
| 89 | Stereotypic behavior (HP:0000733) | 1.94764554 |
| 90 | Amyotrophic lateral sclerosis (HP:0007354) | 1.94285953 |
| 91 | Specific learning disability (HP:0001328) | 1.93535634 |
| 92 | Rigidity (HP:0002063) | 1.93054741 |
| 93 | Abnormality of salivation (HP:0100755) | 1.91684447 |
| 94 | Dysmetric saccades (HP:0000641) | 1.91421119 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 1.90989063 |
| 96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.90989063 |
| 97 | Gait ataxia (HP:0002066) | 1.89915988 |
| 98 | Thickened helices (HP:0000391) | 1.89113905 |
| 99 | Papilledema (HP:0001085) | 1.87029153 |
| 100 | Agitation (HP:0000713) | 1.86084015 |
| 101 | Clumsiness (HP:0002312) | 1.85832149 |
| 102 | Bundle branch block (HP:0011710) | 1.85096714 |
| 103 | Focal dystonia (HP:0004373) | 1.84305945 |
| 104 | Poor suck (HP:0002033) | 1.84154733 |
| 105 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.84046091 |
| 106 | Psychosis (HP:0000709) | 1.83410537 |
| 107 | Abnormality of saccadic eye movements (HP:0000570) | 1.82925666 |
| 108 | Postural tremor (HP:0002174) | 1.82672961 |
| 109 | Incomplete penetrance (HP:0003829) | 1.81066084 |
| 110 | Medial flaring of the eyebrow (HP:0010747) | 1.80182847 |
| 111 | Protruding tongue (HP:0010808) | 1.79853077 |
| 112 | Muscular hypotonia of the trunk (HP:0008936) | 1.79112323 |
| 113 | Congenital primary aphakia (HP:0007707) | 1.78998559 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.78921910 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.78554291 |
| 116 | Prolonged QT interval (HP:0001657) | 1.77915514 |
| 117 | Onion bulb formation (HP:0003383) | 1.75961401 |
| 118 | Obstructive sleep apnea (HP:0002870) | 1.75321855 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75081842 |
| 120 | Genital tract atresia (HP:0001827) | 1.74838210 |
| 121 | Diminished motivation (HP:0000745) | 1.72363292 |
| 122 | Choreoathetosis (HP:0001266) | 1.69814891 |
| 123 | Increased circulating renin level (HP:0000848) | 1.69064496 |
| 124 | Abnormal EKG (HP:0003115) | 1.68933723 |
| 125 | Spastic tetraparesis (HP:0001285) | 1.66704580 |
| 126 | Horizontal nystagmus (HP:0000666) | 1.66501696 |
| 127 | Rapidly progressive (HP:0003678) | 1.62823250 |
| 128 | CNS hypomyelination (HP:0003429) | 1.61401086 |
| 129 | Heterochromia iridis (HP:0001100) | 1.61061238 |
| 130 | Annular pancreas (HP:0001734) | 1.60185233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.26848373 |
| 2 | EPHA4 | 3.89098921 |
| 3 | CASK | 3.45123539 |
| 4 | MAP3K4 | 2.95069302 |
| 5 | MAP3K9 | 2.93482721 |
| 6 | MAP2K7 | 2.81994943 |
| 7 | MARK1 | 2.44969517 |
| 8 | MINK1 | 2.23199748 |
| 9 | TNIK | 2.08807093 |
| 10 | MAP3K12 | 2.07888467 |
| 11 | DAPK2 | 2.04235768 |
| 12 | PAK6 | 1.99881481 |
| 13 | OXSR1 | 1.96391360 |
| 14 | CDK19 | 1.95488607 |
| 15 | RIPK4 | 1.84645322 |
| 16 | NTRK2 | 1.84260473 |
| 17 | NTRK1 | 1.80795044 |
| 18 | MAP2K4 | 1.76369388 |
| 19 | PRPF4B | 1.66789621 |
| 20 | PLK2 | 1.63100258 |
| 21 | STK39 | 1.62738259 |
| 22 | LIMK1 | 1.62010877 |
| 23 | KSR2 | 1.52096010 |
| 24 | CDK5 | 1.44053340 |
| 25 | PNCK | 1.41287587 |
| 26 | MAPK13 | 1.40872574 |
| 27 | GRK5 | 1.37274805 |
| 28 | UHMK1 | 1.35328041 |
| 29 | PRKD3 | 1.33851893 |
| 30 | FES | 1.31876861 |
| 31 | CAMKK1 | 1.29614144 |
| 32 | SGK494 | 1.24681473 |
| 33 | SGK223 | 1.24681473 |
| 34 | MAP3K13 | 1.18924628 |
| 35 | PRKCG | 1.17936193 |
| 36 | TESK1 | 1.16237210 |
| 37 | KSR1 | 1.15506411 |
| 38 | CAMK2A | 1.15383168 |
| 39 | CAMKK2 | 1.15325896 |
| 40 | ARAF | 1.15033517 |
| 41 | CAMK2B | 1.14313929 |
| 42 | BMPR2 | 1.07295903 |
| 43 | MAP4K2 | 1.07050179 |
| 44 | TYRO3 | 1.06582801 |
| 45 | DAPK1 | 1.06200446 |
| 46 | WNK1 | 1.04289083 |
| 47 | FRK | 1.00913922 |
| 48 | PKN1 | 0.95547834 |
| 49 | BCR | 0.92771524 |
| 50 | STK38 | 0.91657399 |
| 51 | MAP3K2 | 0.91267108 |
| 52 | PHKG1 | 0.90052232 |
| 53 | PHKG2 | 0.90052232 |
| 54 | NEK6 | 0.85411747 |
| 55 | SIK2 | 0.85019230 |
| 56 | CDK18 | 0.82097668 |
| 57 | PRKCE | 0.81795743 |
| 58 | STK11 | 0.81777325 |
| 59 | CAMK2D | 0.81717963 |
| 60 | SGK2 | 0.81198247 |
| 61 | CDK15 | 0.79857970 |
| 62 | PRKCH | 0.79766794 |
| 63 | CDK14 | 0.78487940 |
| 64 | PINK1 | 0.77704652 |
| 65 | CSNK1G2 | 0.75645427 |
| 66 | MAPKAPK5 | 0.75415495 |
| 67 | CAMK1 | 0.74975301 |
| 68 | TNK2 | 0.73877559 |
| 69 | FGR | 0.73564625 |
| 70 | CAMK2G | 0.73471646 |
| 71 | PAK3 | 0.73190563 |
| 72 | MUSK | 0.73021232 |
| 73 | CSNK1A1L | 0.72567841 |
| 74 | SGK1 | 0.72434902 |
| 75 | WNK4 | 0.70173348 |
| 76 | CDK11A | 0.67852238 |
| 77 | CAMK4 | 0.67527278 |
| 78 | PTK2B | 0.65630370 |
| 79 | FGFR2 | 0.65479688 |
| 80 | GRK7 | 0.65131879 |
| 81 | AKT3 | 0.64552725 |
| 82 | DYRK1A | 0.63049006 |
| 83 | CSNK1G1 | 0.62948743 |
| 84 | BRSK1 | 0.62200369 |
| 85 | ROCK2 | 0.61843928 |
| 86 | RET | 0.61780275 |
| 87 | LMTK2 | 0.58908045 |
| 88 | ERBB3 | 0.58214541 |
| 89 | ROCK1 | 0.55865639 |
| 90 | MARK2 | 0.54964042 |
| 91 | SGK3 | 0.54076701 |
| 92 | BRAF | 0.53951242 |
| 93 | PDPK1 | 0.52560027 |
| 94 | MAP3K1 | 0.50398641 |
| 95 | NME1 | 0.49249573 |
| 96 | PDK1 | 0.48845112 |
| 97 | CCNB1 | 0.47345286 |
| 98 | FYN | 0.46863465 |
| 99 | ADRBK2 | 0.46515909 |
| 100 | IRAK2 | 0.45778391 |
| 101 | RAF1 | 0.43840917 |
| 102 | WNK3 | 0.43199633 |
| 103 | RPS6KA3 | 0.40952191 |
| 104 | DAPK3 | 0.40150990 |
| 105 | MAPK10 | 0.39720478 |
| 106 | CSNK1D | 0.39392427 |
| 107 | PRKACA | 0.38811450 |
| 108 | PRKCZ | 0.38593732 |
| 109 | MOS | 0.38348986 |
| 110 | PRKCA | 0.37771374 |
| 111 | CDC42BPA | 0.37555380 |
| 112 | MAPK12 | 0.36819526 |
| 113 | FER | 0.36601073 |
| 114 | CSNK1G3 | 0.36575309 |
| 115 | PRKG1 | 0.36517020 |
| 116 | PTK2 | 0.35082938 |
| 117 | CSNK1A1 | 0.35057171 |
| 118 | LATS2 | 0.34775760 |
| 119 | SIK3 | 0.34055693 |
| 120 | DYRK2 | 0.31121647 |
| 121 | MYLK | 0.29102457 |
| 122 | PRKCB | 0.28107784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.01118976 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.35469398 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82647362 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80005446 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.66353944 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.63103875 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57703273 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47002446 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43254274 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.32443204 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.17498190 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07474178 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06164853 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.04618508 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93623076 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91255304 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87303666 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.85190867 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83897009 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82952337 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.64571516 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61776945 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57828249 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57294603 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48401417 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47792386 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39223418 |
| 28 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36619322 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36114871 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29428806 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28425780 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24221228 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.23952937 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21883623 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.21471332 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20536667 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19839061 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10889734 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09502392 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.08920120 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08607787 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01432499 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98180455 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97256087 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96716681 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95976422 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.95963857 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95309889 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93850233 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92306724 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92107314 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91558317 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85681979 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84278256 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81735907 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81093042 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.80176647 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73821599 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73413105 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72776509 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70703695 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68780682 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67687045 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66322806 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64972428 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64091140 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64004242 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60622814 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60406553 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60284146 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60239176 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57909053 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57576536 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57503044 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56928154 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55836369 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54152678 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54044732 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53911320 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51400242 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48035815 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47507647 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.47408935 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46573095 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45554649 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44937883 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44419814 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44072535 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43105895 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42930582 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42502493 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39139411 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.38655401 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37657220 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36839252 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35891286 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34575018 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.34076817 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33611256 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33611084 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33280437 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33064389 |
| 103 | Protein export_Homo sapiens_hsa03060 | 0.32907228 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32197566 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32133416 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31973216 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31866905 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31824858 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.30968444 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30867250 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30839697 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29396620 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.29095382 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28842305 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.28454156 |
| 116 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28202479 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.27344659 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25225829 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24774686 |

